Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Organon & Co is a global healthcare company based in the United States, dedicated to improving women's health. The company develops and distributes innovative medicines across reproductive health, biosimilars, and a diverse portfolio of established pharmaceutical brands.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Organon & Co is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Organon & Co last reported quarterly earnings on 4/30/2026 (Q1 2026). Earnings per share (EPS) came in at 0.71 USD.
Across its last 3 earnings reports, Organon & Co stock moved by ±6.6% on average the following day. The largest reaction was +11% on 02/13/2025; 1 of 3 reactions were positive.
Organon & Co has beaten analyst EPS estimates in 1 of its last 4 evaluated quarters (beat rate: 25%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.